Spectrophotometric and liquid chromatographic determination of fenofibrate and vinpocetine and their hydrolysis products

Farmaco

Volumn 60, Issue 5, 2005, Pages 425-438

  El Gindy, Alaa ^a   Emara, Samy ^a   Mesbah, Mostafa K ^a   Hadad, Ghada M ^a  

^a Suez Canal University   (Egypt)

Author keywords

Chemometry; Derivative ratio spectra; Derivative spectrophotometry; Fenofibrate; HPLC; Kinetics of hydrolysis; pH rate profile; Vinpocetine

Indexed keywords

ACETONITRILE; ACID; DIETHYLAMINE; DRUG METABOLITE; FENOFIBRATE; VINPOCETINE; WATER;

ACIDITY; ALKALINITY; ARTICLE; DRUG DETERMINATION; DRUG HYDROLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; PRINCIPAL COMPONENT ANALYSIS; PROCESS DEVELOPMENT; ROBINSON ANNULATION; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS; ULTRAVIOLET SPECTROSCOPY;

ANTICONVULSANTS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INDUSTRY; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; LEAST-SQUARES ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PROCETOFEN; SPECTROPHOTOMETRY, ULTRAVIOLET; VINCA ALKALOIDS;

EID: 19444387953     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2005.01.013     Document Type: Article

References (31)

1. S.C. Sweetman Martindale--The Complete Drug Reference, Thirty-third ed 2002 Pharmaceutical Press
2. K. Reddersen, and T. Heberer Multi-compound methods for the detection of pharmaceutical residues in various waters applying solid phase extraction (SPE) and gas chromatography with mass spectrometric (GC-MS) detection J. Sep. Sci. 26 2003 1443 1450
3. F. Sacher, F.T. Lange, H.J. Brauch, and I. Blankenhorn Pharmaceuticals in groundwaters. Analytical methods and results of a monitoring program in Baden-Wurttemberg, Germany J. Chromatogr. A. 938 2001 199 210
4. D.H. Calan British Pharmacopeia 2001 Her Majesty Stationery Office London
5. D. Schnädelbach European Pharmacopoeia, Fourth ed 2002 Council of Europe Strasbourg, France
6. L.A. Romanyshyn, and P.R. Tiller Ultra-short columns and ballistic gradients: considerations for ultra-fast chromatographic liquid chromatographic-tandem mass spectrometric analysis J. Chromatogr. A. 928 2001 41 51
7. G.R. Fan, M. Lin, Z.X. Zhang, and D.K. An Determination of the fenofibrate bioactive metabolite, fenofibric acid, in human plasma by HPLC Yaowu Fenxi Zazhi 20 2000 231 234
8. B. Streel, P. Hubert, and A. Ceccato Determination of fenofibric acid in human plasma using automated solid-phase extraction coupled to liquid chromatography J. Chromatogr. B Biomed. Appl. 742 2000 391 400
9. S. Abe, K. Ono, M. Mogi, and T. Hayashi High-performance liquid-chromatographic method for the determination of fenofibric acid and reduced fenofibric acid in human blood, plasma and urine Yakugaku Zasshi 118 1998 447 455
10. L.D. Masnatta, L.A. Cuniberti, R.H. Rey, and J.P. Werba Determination of bezafibrate, ciprofibrate and fenofibric acid in human plasma by high-performance liquid chromatography J. Chromatogr. B Biomed. Appl. 687 1996 437 442
11. A. Cotta Ramusino, and A. Carozzi Simple and rapid method for determining procetofenic acid, an active metabolite of procetofen [fenofibrate], in biological fluids by solid-phase extraction and high-performance liquid chromatography J. Chromatogr. Biomed. Appl. 56 1986 419 424 (2 (J. Chromatogr. 383))
12. R.N. Rao, and V. Nagaraju An overview of the recent trends in development of HPLC methods for determination of impurities in drugs J. Pharm. Biomed. Anal. 33 2003 335 377
13. X. Ji, and C. Ye Determination of the impurities and content of fenofibrate by reversed-phase HPLC Zhongguo Yaoke Daxue Xuebao 18 1987 284 286
14. P.M. Lacroix, B.A. Dawson, R.W. Sears, D.B. Black, T.D. Cyr, and J.C. Ethier Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity J. Pharm. Biomed. Anal. 18 1998 383 402
15. M. Gazdag, G. Szepesi, and K. Csomor High-performance liquid chromatography of eburnane alkaloids. III. Application of different phase systems J. Chromatogr. 243 1981 315 322
16. X. Wang Determination of vinpocetine and related substances in pharmaceutical tablets by HPLC Yaowu Fenxi Zazhi 15 1995 23 26
17. A. Abd Elbary, N. Foda, O. El-Gazayerly, and M. El Khatib Reversed-phase liquid chromatographic determination of vinpocetine in human plasma and its pharmacokinetic applications Anal. Lett. 35 2002 1041 1054
18. B. Herenyi, and S. Goeroeg Chiral high-performance liquid-chromatographic separations on an 1-acid glycoprotein column. II. Separation of the diastereomeric and enantiomeric analogues of vinpocetine (Cavinton) J. Chromatogr. 592 1992 297 299
19. B. Reck, E. Dingler, and A. Lohmann Development of a sensitive enzyme immunoassay for the determination of vinpocetine in human plasma Arzneim.- Forsch. 42 1992 1171 1174
20. M. Vatsova, S. Tzvetanov, A. Drenska, J. Goranscheva, and N. Tyutyulkova Improved gas chromatographic-mass-spectrometric method for the quantitative determination of vinpocetine in human plasma J.Chromatogr. B, Biomed. Appl. 702 1997 221 226
21. A. Lohmann, and E. Dingler New assay method for the determination of vinpocetine in human plasma by gas chromatography-mass spectrometry without trans-esterification caused by solvents. Reply to Hammes and Weyhenmeyer J. Chromatogr. Biomed. Appl. 105 1991 506 507 (2 (J. Chromatogr. 567))
22. W. Hammes, and R. Weyhenmeyer New assay method for the determination of vinpocetine in human plasma by gas chromatography-mass spectrometry without trans-esterification caused by solvents: a reply J. Chromatogr. Biomed. Appl. 105 1991 504 505 (2 (J. Chromatogr. 567))
23. A. Lohmann, and E. Dingler New assay method for the determination of vinpocetine in human plasma with gas chromatography-mass spectrometry without transesterification caused by solvents J. Chromatogr. Biomed. Appl. 94 1990 442 448 (2 (J. Chromatogr. 529))
24. W. Hammes, and R. Weyhenmeyer Quantitative determination of vinpocetine in human plasma by capillary gas chromatography-mass spectrometry J. Chromatogr. Biomed. Appl. 57 1987 264 269 (J. Chromatogr. 413)
25. B.M. Wise, N.B. Gallagher, PLS-Toolbox Version 2.1, Eigenvector Research, Inc., 830 Wapato Lake road, Manson, W A 98831, 2000.
26. M. Brezina, and P. Zuman Polarography in Medicine, Biochemistry, and Pharmacy 1958 Interscience New York p.731
27. M. Blanco, J. Coello, F. Gonzalez, H. Iturriaga, and S. Maspoch Spectrophotometric analysis of a pharmaceutical preparation by principal component regression J. Pharm. Sci. 82 1993 834 837
28. A. Espinosa-Mansilla, F. salinas, and I. De Orbe Paya Simultaneous determination of sulfadiazine, doxycycline, furaltadone and trimethoprim by partial least squares multivariate calibration Anal. Chim. Acta 313 1995 103 112
29. D.M. Haaland, and E.V. Thomas Partial least-squares methods for spectral analyses. 1. Relation to other quantitative calibration methods and the extraction of qualitative information Anal. Chem. 60 1988 1193 1202
30. J.A. De Schutter, and P. De Moerloose Determination of oxybutynin hydrochloride in pharmaceuticals by reversed-phase ion-pair liquid chromatography with two counter-ions in the eluent J. Chromatogr. 450 1988 337 342
31. The European Agency for The Evaluation of Medical Products, ICH Topic Q2B Note for Guidance on Validation of Analytical Procedures: Methodology GPMP/ICH/281/95,1996.